Remarkable response to chidamide plus rituximab in an elderly patient with recurrent, chemotherapy-refractory diffuse larger B-cell lymphoma carrying CREBBP mutation

被引：0
|
作者：
Zhang, Dongdong [1 ]
Han, Yidi [1 ]
Dong, Youhong [1 ]
机构：
[1] Hubei Univ Med, Xiangyang Peoples Hosp 1, Dept Oncol, Xiangyang 441000, Peoples R China
来源：
ANNALS OF HEMATOLOGY | 2023年 / 102卷 / 05期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1007/s00277-023-05183-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1265 / 1268
页数：4
相关论文
共 50 条
  • [21] Phase III trial of bendamustine plus rituximab for relapsed or refractory diffuse large B-cell lymphoma in Japan
    Kiguchi, Toru
    Terui, Yasuhito
    Izutsu, Koji
    Kameoka, Yoshihiro
    Hidaka, Michihiro
    Kato, Harumi
    Matsumura, Itaru
    Kuroda, Junya
    Ishizawa, Kenichi
    Ichikawa, Satoshi
    Ando, Kiyoshi
    Ogura, Michinori
    Tobinai, Kensei
    Fukushima, Koji
    Murayama, Kayoko
    ANNALS OF ONCOLOGY, 2021, 32 : S304 - S304
  • [22] Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin’s lymphoma
    Philipp Kiewe
    Eckhard Thiel
    Annals of Hematology, 2011, 90 : 109 - 110
  • [23] Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma
    Kiewe, Philipp
    Thiel, Eckhard
    ANNALS OF HEMATOLOGY, 2011, 90 (01) : 109 - 110
  • [24] Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy
    Li, Qing
    Huang, Jingcao
    Ou, Yang
    Li, Yan
    Wu, Yu
    IMMUNOTHERAPY, 2019, 11 (04) : 265 - 272
  • [25] A phase 2 study of polatuzumab vedotin plus bendamustine plus rituximab in relapsed/refractory diffuse large B-cell lymphoma
    Terui, Yasuhito
    Rai, Shinya
    Izutsu, Koji
    Yamaguchi, Motoko
    Takizawa, Jun
    Kuroda, Junya
    Ishikawa, Takayuki
    Kato, Koji
    Suehiro, Youko
    Fukuhara, Noriko
    Ohmine, Ken
    Goto, Hideki
    Yamamoto, Kazuhito
    Kanemura, Nobuhiro
    Ueda, Yasunori
    Ishizawa, Kenichi
    Kumagai, Kyoya
    Kawasaki, Atsuko
    Saito, Tomohisa
    Hashizume, Misato
    Shibayama, Hirohiko
    CANCER SCIENCE, 2021, 112 (07) : 2845 - 2854
  • [26] DexaBEAM plus Rituximab as second salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma with response failure to platinum-based first salvage regimen
    Mikesch, J-H
    Demant, A.
    Kuhlmann, M.
    Krug, U.
    Schmidt, E.
    Thoennissen, G. B.
    Koehler, G.
    Wessling, J.
    Mesters, R. M.
    Mueller-Tidow, C.
    Berdel, W. E.
    Thoennissen, N. H.
    ONKOLOGIE, 2013, 36 : 142 - 142
  • [27] Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: Role of rituximab, high-dose therapy, and allogeneic stem cell transplantation
    Nath, SV
    Seymour, JF
    LEUKEMIA & LYMPHOMA, 2005, 46 (07) : 1075 - 1079
  • [28] Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma
    Linderoth, Johan
    Eden, Patrik
    Ehinger, Mats
    Valcich, Jeanette
    Jerkeman, Mats
    Bendahl, Par-Ola
    Berglund, Mattias
    Enblad, Gunilla
    Erlanson, Martin
    Roos, Goran
    Cavallin-Stahl, Eva
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (04) : 423 - 432
  • [29] INOTUZUMAB OZOGAMICIN IN B-CELL NON-HODGKIN'S LYMPHOMA REFRACTORY TO RITUXIMAB plus CHEMOTHERAPY OR RADIOIMMUNOTHERAPY
    Ogura, M.
    Leach, J.
    Egyed, M.
    Ando, K.
    Hatake, K.
    Tobinai, K.
    Feldman, T.
    Hua, S.
    Volkert, A.
    Vandendries, E.
    Goy, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 94 - 94
  • [30] Cryptococcemia in an Elderly Woman with Retroperitoneal Diffuse Large B-cell Lymphoma after Rituximab-containing Chemotherapy
    Cheng, Ming-Wei
    Wu, Alice Ying-Jung
    Liu, Chang-Pang
    Lim, Ken-Hong
    Weng, Shu-Ling
    Tseng, Hsiang-Kuang
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2016, 10 (02) : 112 - 116
12345